<DOC>
	<DOCNO>NCT00900042</DOCNO>
	<brief_summary>RATIONALE : DNA analysis tumor tissue may help doctor predict well patient respond treatment . PURPOSE : This laboratory study analyze DNA tumor tissue patient metastatic kidney cancer .</brief_summary>
	<brief_title>SWOG-9023 , DNA Analysis Tumor Tissue From Patients With Metastatic Kidney Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine cytogenetic abnormality predict clinical outcome , term response treatment survival , patient metastatic renal cell carcinoma register nephrectomy arm ( arm I ) SWOG-8949 . - Correlate cytogenetic abnormality DNA content analysis ( DNA index S-phase fraction ) clinical outcome . OUTLINE : This partially prospective , partially retrospective , multicenter , companion study . Paraffin-embedded tumor tissue specimens patient enrol SWOG-8949 evaluate cytogenetic analysis ( e.g. , presence trisomy loss Y chromosome ) flow cytometric analysis ( e.g. , presence nondiploid cell presence abnormal proliferation index ) . PROJECTED ACCRUAL : A total 80 patient accrue study .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis renal cell carcinoma Any T , N , M1 disease specify SWOG8949 Eligible register nephrectomy arm* ( arm I ) SWOG8949 NOTE : *Patients must register study undergo nephrectomy SWOG8949 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>stage IV renal cell cancer</keyword>
</DOC>